[
  {
    "from_address": "m.garcia@goldenstateclinical.com",
    "to_addresses": [
      "kevin.chen@syneoshealth.com"
    ],
    "cc_addresses": [
      "e.carter@goldenstateclinical.com"
    ],
    "subject": "New SAE Report - BIIB122/DNL151 - Site 101",
    "timestamp": "2024-05-21T14:30:00Z",
    "body": "Hi Kevin,\n\nPlease see the attached initial CIOMS form for a new Serious Adverse Event (SAE) for patient 101-005.\n\nBest regards,\n\nMaria Garcia\nSite Coordinator\nGolden State Clinical Research",
    "attachments": [
      "SAE_CIOMS_BIIB122_101-005_Initial.pdf"
    ],
    "message_id": 0,
    "in_reply_to": null
  },
  {
    "from_address": "kevin.chen@syneoshealth.com",
    "to_addresses": [
      "alex.johnson@denalitx.com"
    ],
    "cc_addresses": [
      "sarah.lee@syneoshealth.com"
    ],
    "subject": "Fwd: New SAE Report - BIIB122/DNL151 - Site 101",
    "timestamp": "2024-05-21T14:45:10Z",
    "body": "Hi Alex,\n\nPlease see the new SAE report from Site 101 for study BIIB122/DNL151. The initial CIOMS form is attached for your review and submission to the Denali and Biogen safety teams.\n\nThanks,\n\nKevin Chen\nClinical Research Associate\nSyneos Health",
    "attachments": [
      "SAE_CIOMS_BIIB122_101-005_Initial.pdf"
    ],
    "message_id": 1,
    "in_reply_to": 0
  }
]